Viral Vector Process Development Summit
Evvnt Promotion / evvnt
Archivo
31.01.2023 - 02.02.2023 Omni Parker House, 60 School Street, 02108 Boston, Massachusetts, USA
Time: 9:00 am - 4:30 pm
Temas de la conferencia
As cell and gene therapy and genomic medicine pipeline continues to mature, process development for viral vector is becoming critical for drug developers for the next phase, to deliver a quality, transformative cure to patients with affordability.
As cell and gene therapy and genomic medicine pipeline continues to mature, process development for viral vector is becoming critical for drug developers for the next phase, to deliver a quality, transformative cure to patients with affordability.
La Sociedad Científica
Hanson Wade
Hanson Wade
Observaciones
URL:
Website: https://go.evvnt.com/1322215-3?pid=4832
Speakers: Rajiv Gangurde | Chief Technology Officer | SparingVision, Susan D'Costa | Executive VP and Global Head, Technology | Alcyone Therapeutics, and more.
URL:
Website: https://go.evvnt.com/1322215-3?pid=4832
Speakers: Rajiv Gangurde | Chief Technology Officer | SparingVision, Susan D'Costa | Executive VP and Global Head, Technology | Alcyone Therapeutics, and more.
Información e inscripción:
https://go.evvnt.com/1322215-2?pid=4832
Ms. Stephanie Nketia
Medicina General
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
